For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Syros Pharmaceuticals Inc (NASDAQ: SYRS) closed the day trading at $0.24 up 1.52% from the previous closing price of $0.24. In other words, the price has increased by $1.52 from its previous closing price. On the day, 2.29 million shares were traded. SYRS stock price reached its highest trading level at $0.2468 during the session, while it also had its lowest trading level at $0.2222.
Ratios:
For a better understanding of SYRS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.25 and its Current Ratio is at 2.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on November 04, 2020, Upgraded its rating to Buy and sets its target price to $15 from $11 previously.
On September 22, 2020, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $18.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when Simonian Nancy A sold 37,070 shares for $0.27 per share. The transaction valued at 10,016 led to the insider holds 4,000 shares of the business.
Nancy Cole bought 37,070 shares of SYRS for $10,016 on Dec 02 ’24. On Nov 25 ’24, another insider, Simonian Nancy A, who serves as the Director of the company, sold 134,713 shares for $0.27 each. As a result, the insider received 35,739 and left with 41,070 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRS now has a Market Capitalization of 6439800 and an Enterprise Value of 8390790. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.76. Its current Enterprise Value per Revenue stands at 21.738 whereas that against EBITDA is -0.076.
Stock Price History:
Over the past 52 weeks, SYRS has reached a high of $8.17, while it has fallen to a 52-week low of $0.18. The 50-Day Moving Average of the stock is -84.50%, while the 200-Day Moving Average is calculated to be -94.01%.
Shares Statistics:
Over the past 3-months, SYRS traded about 8.17M shares per day on average, while over the past 10 days, SYRS traded about 3319570 shares per day. A total of 26.83M shares are outstanding, with a floating share count of 17.43M. Insiders hold about 35.20% of the company’s shares, while institutions hold 36.36% stake in the company. Shares short for SYRS as of 1731628800 were 4773354 with a Short Ratio of 0.58, compared to 1728950400 on 952604. Therefore, it implies a Short% of Shares Outstanding of 4773354 and a Short% of Float of 19.36.
